Brightmeds review

Brightmeds keeps its peptide pricing simple. Sermorelin and NAD⁺ injections are each $129 a month and glutathione is $99, billed monthly, cancel anytime, with the medication, clinician review and shipping included and a stated promise that the price does not rise later. Testosterone is handled carefully: lab work first, a prescription only when testing confirms low testosterone, and an explicit refusal to prescribe for performance. The gaps are disclosure ones. No pharmacy is named, no individual clinician is named, the product pages do not state the vial size or dose, and testosterone has no published price, while the terms describe a $100 lab fee that the testosterone page calls free.

A telehealth platform operated by Brightmeds LLC selling compounded sermorelin, NAD⁺ and glutathione injections; testosterone replacement as injections, capsules or cream; compounded semaglutide and tirzepatide, including microdosing protocols; and branded Zepbound pens and vials. For Zepbound, Brightmeds charges a $100 doctor consult fee and the prescription goes to LillyDirect or a local pharmacy, which bills the medication separately. Its terms describe it as a portal that coordinates care rather than a healthcare provider: prescribing is done by affiliated medical groups, named in its telehealth consent as Vital, an affiliate of OpenLoop Healthcare Partners, and Reliant MD Medical Associates.

Telehealth only. For the peptides, you complete a short online intake, a licensed clinician reviews it, and if treatment is appropriate the medication ships in temperature-safe, unbranded packaging with dosing guidance and ongoing support. There is no separate consultation, prescribing or lab fee for the sermorelin, NAD⁺ or glutathione plans, and if you are not approved you get a full refund. Testosterone runs differently and more carefully: an eligibility questionnaire, then a blood test of testosterone and key health markers, then a consultation reviewing the results with an affiliated doctor, and a prescription only if lab testing confirms low testosterone. The site states that TRT is not prescribed for performance enhancement or cosmetic purposes. One inconsistency: the testosterone page describes the blood test as "free of cost," while the terms set an initial lab test fee of $100, folded into the program price if you proceed and kept, non-refundable, if you stop after the test. The terms list service in 47 states, excluding Alabama, Arkansas and Mississippi. The compounding pharmacies are described only as US state-licensed sterile compounding pharmacies, and no individual clinician is named. You can pause or cancel from your account or by email.

The peptide plans are simple. Sermorelin is $129 a month, NAD⁺ $129 and glutathione $99, each "billed monthly … one month at a time — no packs, no bundles," renewing automatically until you cancel. Each covers the medication, the clinical evaluation, clinician follow-up, dosing guidance and standard shipping, with no membership fee. The pages run under a "Fall Savings" banner but state that the rate is locked for as long as you stay on the plan, with no step-up after the first month, and they say there is no intro rate. What the pages do not say is how much peptide each month's supply contains, which makes it harder to compare cost per milligram with sellers that state the vial size. Testosterone has no published price. Branded Zepbound costs a $100 consult fee, with the pens or vials paid to the pharmacy. Refunds are narrow beyond the not-approved guarantee: the terms say fees paid are otherwise non-refundable, in whole or in part, given the nature of the medication.

Compounded; not FDA-approved — and Brightmeds' disclosure of that is specific. It names the 503A and 503B distinction rather than gesturing at "licensed pharmacies", states the products are not FDA-approved, warns that it can be challenging to directly compare the results and risk profiles of FDA-approved and compounded medicines, and carries the standard statement that its claims have not been reviewed by the FDA. Its branded Zepbound line is properly separated from the compounded catalog, with an FDA-approved badge that is accurate for that product, a disclosed consult fee, and the medication itself billed separately by the pharmacy. Trademark disclaimers correctly disavow affiliation with the brand manufacturers, including on the testosterone page. On the evidence: sermorelin is a GHRH analog acting on your own pituitary, a real mechanism with thin long-term human outcome data. Injected NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN raise blood NAD⁺, a biomarker rather than a demonstrated benefit. Injected glutathione for skin and immunity has very little controlled human evidence. Testosterone replacement is the one therapy here with a large randomized safety base, and it requires ongoing monitoring. Individual results vary.